{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001039398.3:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_001039398.3",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S (p.G2019S)"
        },
        {
          "HGVS": "NM_001039398.3:c.4322G>T",
          "cDNA Change": {
            "transcript": "NM_001039398.3",
            "ref": "G",
            "alt": "T",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C (p.R1441C)"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's Disease",
    "MONDO": "MONDO:0005042"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were transfected with LRRK2 variants and analyzed by Western Blot."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001039398.3:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased phosphorylation of LRRK2 at S935 and S1290 in G2019S variant."
        },
        {
          "Variant": "NM_001039398.3:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Reduced phosphorylation of LRRK2 at S935 and S1290 in R1441C variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by post-hoc Tukey's test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels ≥ 80% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels < 50% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cell Viability Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "SH-SY5Y",
        "Description": "SH-SY5Y cells were treated with LRRK2 variants and assessed for viability."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001039398.3:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "G2019S variant reduced cell viability by 35% compared to wild-type."
        },
        {
          "Variant": "NM_001039398.3:c.4322G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "R1441C variant reduced cell viability by 20% compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 cDNA was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "Yes",
        "Counts": "1"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA followed by post-hoc Tukey's test was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cell viability ≥ 85% of wild-type control.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cell viability < 70% of wild-type control.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}